JAK1 and posterior cortical atrophy: To identify novel druggable targets that could enhance docetaxel sensitivity in PCa, we queried the lethality hits against the Drug Gene Interaction Database (DGIdb) and identified JAK1 and IGF1R as druggable targets with existing FDA‐approved or experimental inhibitors (Figure 1D).